Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Long-Term Deferred Tax came in at $6.7 billion in Q2 2026, down 1.07% year-over-year from $6.8 billion in Q2 2025, and little changed quarter-over-quarter from $6.7 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $6.7 billion for Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 1.07% year-over-year to $6.7 billion; the TTM figure through Jun 2026 stood at $6.7 billion (down 1.07% YoY), while the FY2025 annual figure was $6.9 billion, down 34.29% from the prior year.
- Long-Term Deferred Tax came in at $6.7 billion for Q2 2026 at Johnson & Johnson, roughly flat from $6.7 billion in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 billion in Q4 2024 to a low of $6.7 billion in Q3 2025.
- Average Long-Term Deferred Tax over 5 years is $8.7 billion, with a median of $9.0 billion recorded in 2024.
- Year-over-year, Long-Term Deferred Tax increased 19.79% in 2022 and slumped 34.29% in 2025.
- Over 5 years, Long-Term Deferred Tax stood at $9.4 billion in 2022, then decreased by 1.2% to $9.3 billion in 2023, then increased by 12.74% to $10.5 billion in 2024, then tumbled by 34.29% to $6.9 billion in 2025, then slipped by 2.12% to $6.7 billion in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $6.7 billion in Q2 2026, $6.7 billion in Q1 2026, and $6.9 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 6.73 Bn |
| Mar 29, 2026 | 6.73 Bn |
| Dec 28, 2025 | 6.87 Bn |
| Sep 28, 2025 | 6.67 Bn |
| Jun 29, 2025 | 6.80 Bn |
| Mar 30, 2025 | 8.49 Bn |
| Dec 29, 2024 | 10.46 Bn |
| Sep 29, 2024 | 9.35 Bn |
| Jun 30, 2024 | 9.00 Bn |
| Mar 31, 2024 | 10.31 Bn |
| Dec 31, 2023 | 9.28 Bn |
| Oct 1, 2023 | 9.26 Bn |
| Jul 2, 2023 | 8.78 Bn |
| Apr 2, 2023 | 8.82 Bn |
| Jan 1, 2023 | 8.95 Bn |
| Oct 2, 2022 | 9.39 Bn |
| Jul 3, 2022 | 9.51 Bn |
| Apr 3, 2022 | 9.94 Bn |
| Jan 2, 2022 | 10.22 Bn |
| Oct 3, 2021 | 10.65 Bn |